Bruce Leuchter

Bruce Leuchter, M.D. is currently the President & CEO of Neurvati Neurosciences, a company focused on developing technologies for neurological and psychiatric disorders.12 He is no longer a Partner at PJT Partners, as he previously held that position.2

Dr. Leuchter has a diverse background spanning clinical practice, academia, finance, and biotechnology:

1. Medical Career:

   • Completed residency training in Neurology and Psychiatry at New York Presbyterian Hospital and Weill Cornell Medical College23
   • Served as Director of Clinical Neuropsychiatry at Weill Cornell Medical College23
   • Maintains a voluntary faculty appointment in the Department of Psychiatry at Weill Cornell3

2. Financial Industry Experience:

   • Worked as a Partner at PJT Partners, providing M&A and capital markets advisory services to biotechnology companies2
   • Held roles in equity research at Goldman Sachs and investment banking at Credit Suisse23

3. Current Roles:

   • Co-founder and President & CEO of Neurvati Neurosciences since September 20213
   • Co-founder and Senior Advisor of Click Therapeutics, a digital therapeutics company2

4. Education:

   • Bachelor of Arts from the University of Michigan1
   • Medical Doctor (M.D.) from Wayne State University School of Medicine13

Dr. Leuchter's expertise spans clinical neuropsychiatry, biotechnology equity research, healthcare investment banking, and drug development.3 He is known for his passion for knowledge and commitment to serving patients and families in need across various roles in academia, clinical medicine, financial services, and industry.2